Expression of the nonmuscle myosin heavy chain IIA in the human kidney and screening for MYH9 mutations in Epstein and Fechtner syndromes.
about
APOL1 localization in normal kidney and nondiabetic kidney diseaseMYH9 is a major-effect risk gene for focal segmental glomerulosclerosisRole of Natural Autoantibodies and Natural IgM Anti-Leucocyte Autoantibodies in Health and DiseaseCell biology and pathology of podocytesA genome-wide association study for diabetic nephropathy genes in African AmericansEstablishment of mouse model of MYH9 disorders: heterozygous R702C mutation provokes macrothrombocytopenia with leukocyte inclusion bodies, renal glomerulosclerosis and hearing disability.Inherited platelet disorders: thrombocytopenias and thrombocytopathies.MYH9 nephropathy.Identification of a putative network of actin-associated cytoskeletal proteins in glomerular podocytes defined by co-purified mRNAsAngiotensin II stimulates trafficking of NHE3, NaPi2, and associated proteins into the proximal tubule microvilli.Translating associations between common kidney diseases and genetic variation into the clinicIs collapsing C1q nephropathy another MYH9-associated kidney disease? A case report.Essential hypertension and risk of nephropathy: a reappraisal.The glomerulus--a view from the outside--the podocyte.The spectrum of MYH9-associated nephropathyRisk factors for progression of chronic kidney disease.Polymorphisms in the non-muscle myosin heavy chain gene (MYH9) are associated with lower glomerular filtration rate in mixed ancestry diabetic subjects from South Africa.APOL1 null alleles from a rural village in India do not correlate with glomerulosclerosis.Recent developments in HIV-related kidney disease.Genetic susceptibility to idiopathic membranous nephropathy in high-prevalence Area, TaiwanBiophysical properties of normal and diseased renal glomeruli.The MYH9/APOL1 region and chronic kidney disease in European-Americans.Pathogenesis of glomerular haematuria.Polymorphisms in MYH9 are associated with diabetic nephropathy in European AmericansProgress in pathogenesis of proteinuria.African American living-kidney donors should be screened for APOL1 risk alleles.The genetic risk of kidney disease in type 2 diabetes.Medaka fish, Oryzias latipes, as a model for human obesity-related glomerulopathy.Genetic contribution and associated pathophysiology in end-stage renal diseaseOf mice and men: Relevance of cellular and molecular characterizations of myosin IIA to MYH9-related human disease.Susceptibility loci for murine HIV-associated nephropathy encode trans-regulators of podocyte gene expression.Actin-associated Proteins in the Pathogenesis of Podocyte InjuryTaking a hard look at the pathogenesis of childhood HIV-associated nephropathy.Septin 7 reduces nonmuscle myosin IIA activity in the SNAP23 complex and hinders GLUT4 storage vesicle docking and fusion.Molecular mechanisms of receptor-mediated endocytosis in the renal proximal tubular epithelium.Podocyte-specific deletion of Myh9 encoding nonmuscle myosin heavy chain 2A predisposes mice to glomerulopathy.Molecular and genetic basis of inherited nephrotic syndromeHuman genetics of nephrotic syndrome and the quest for precision medicine.The ADF/Cofilin-Pathway and Actin Dynamics in Podocyte Injury.MYH9 E1841K Mutation Augments Proteinuria and Podocyte Injury and Migration.
P2860
Q24631960-344ADA7A-9FB3-4906-9357-A6AFDE373FAAQ24643421-5E744965-5FB4-450D-83D7-F1011B1E3667Q26745015-85E66DDA-43D2-4BA4-A835-FF73477DF8ABQ26853664-1548633B-148A-4F76-B4C8-00E18BFDE155Q28943287-03D8E4DC-AA8C-4981-83D2-3B0FF7C2515AQ31127014-8685118C-0486-4532-B280-104DF3E7D70CQ33387543-53A99DBA-3FD3-4F1F-A44C-F95AE8B28E78Q33426872-375A0041-8C2E-4F6B-A000-C9BF47FEF0B2Q33490128-5AB0CC42-62F6-4244-8794-25E2C0A16A91Q33589114-F1ABFB56-6120-4FB4-AA44-F8F9F16B6EC7Q33762596-DCCD58BB-264E-4C84-8B0C-46596ECF54C2Q33828986-71BFC17A-14C8-4595-8647-5E5C5926FF0FQ33997784-82AD2C5A-6618-42DB-B720-9706ECB8C904Q34020798-60425EF5-BEA8-4820-8B5E-D8CE13409BD4Q34105121-41AE3D16-30C7-4FD3-9E45-4394FA015A70Q34169794-DA5F85A6-EEEE-47AD-B9E3-7E05C5B9F921Q34534055-695126B7-8D6D-415A-BA56-4F0CB3FAA5DEQ34540191-EE74C5A0-BF74-435E-AB63-C0179CE1A6F6Q34572458-E265DC0E-0504-4FF1-89C4-AEA5557B9D5EQ34691828-632BBB04-A942-4DA4-B44C-2EA2E6E1C4A7Q34717990-1115B730-CEF1-46B4-9C7A-704BB44B95E8Q34994823-D1CC1FD9-1C74-41F5-855E-4C2323D77536Q35567846-B80493FF-7AFC-45A0-A706-4C1B639370DBQ35861454-57E72190-4AC2-4427-B56C-A46CF088BD6FQ36011008-9AA00211-4D06-48EB-BDC9-A8A8C6E37892Q36207762-2316BAF7-5AF1-4CBE-B030-AC1DDEB9BDB5Q36515022-377B36A9-76E8-446A-AF5D-4E90059CA6B6Q36654960-76416063-4EC2-45DE-B4BE-C08435AB7E88Q36925161-38DD2064-CC6C-4AD8-B73C-880B11E4FCF3Q37079919-3203BDB1-6E7D-4C9E-ACDA-EFAA741576C6Q37170764-A42EE808-DD98-43C3-AD45-238A0B2CA494Q37402598-4398A5B1-9DF8-49F0-9C6B-44DD8B046FD5Q37415434-18EDEC32-E989-433B-A608-64EB62CE8BB4Q37592438-9DA1C61B-9B4E-496C-8A2A-264EE6F36E04Q37654819-DCD35CC0-DE36-40CB-9D1E-81132F03F0F2Q37852917-0E97CB0D-1A56-4171-B534-E18D67C1AD7AQ38310654-E5E50A01-0307-4A07-A2C0-C8DAA7C4109DQ38393601-72CB1AFC-8211-4CAA-BC52-D91CCBF3BD64Q39725372-4B46DB53-E8F2-4AAC-863D-58372FAC3873Q45069613-F207F6B5-7752-43E3-BAB4-8802F78CE57E
P2860
Expression of the nonmuscle myosin heavy chain IIA in the human kidney and screening for MYH9 mutations in Epstein and Fechtner syndromes.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Expression of the nonmuscle my ...... pstein and Fechtner syndromes.
@ast
Expression of the nonmuscle my ...... pstein and Fechtner syndromes.
@en
type
label
Expression of the nonmuscle my ...... pstein and Fechtner syndromes.
@ast
Expression of the nonmuscle my ...... pstein and Fechtner syndromes.
@en
prefLabel
Expression of the nonmuscle my ...... pstein and Fechtner syndromes.
@ast
Expression of the nonmuscle my ...... pstein and Fechtner syndromes.
@en
P2093
P1476
Expression of the nonmuscle my ...... pstein and Fechtner syndromes.
@en
P2093
Bertrand Knebelmann
Christelle Arrondel
Corinne Antignac
Jean-Pierre Grünfeld
Laurence Heidet
Marie-Claire Gubler
Nicolas Vodovar
P577
2002-01-01T00:00:00Z